{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T04:01:39Z","timestamp":1790740899944,"version":"4.1.0"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bone"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.bone.2026.118070","type":"journal-article","created":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T15:07:20Z","timestamp":1787756840000},"page":"118070","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["ZCCHC4-mediated m6A methylation regulates the UHRF1\/CDO1 axis to inhibit ferroptosis and promote osteosarcoma malignant progression"],"prefix":"10.1016","volume":"213","author":[{"given":"Kai","family":"Song","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ju","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bowen","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huazhang","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dasheng","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bone.2026.118070_bb0005","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/bph.15713","article-title":"Osteosarcoma mechanobiology and therapeutic targets","volume":"179","author":"Shoaib","year":"2022","journal-title":"Br. J. Pharmacol."},{"issue":"Suppl. 2","key":"10.1016\/j.bone.2026.118070_bb0010","article-title":"Osteosarcoma","volume":"68","author":"Eaton","year":"2021","journal-title":"Pediatr. Blood Cancer"},{"key":"10.1016\/j.bone.2026.118070_bb0015","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/s12943-023-01804-z","article-title":"Exosome-mediated miR-144-3p promotes ferroptosis to inhibit osteosarcoma proliferation, migration, and invasion through regulating ZEB1","volume":"22","author":"Jiang","year":"2023","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.bone.2026.118070_bb0020","article-title":"An update on the roles of circular RNAs in osteosarcoma","volume":"54","author":"Li","year":"2021","journal-title":"Cell Prolif."},{"key":"10.1016\/j.bone.2026.118070_bb0025","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1038\/s41571-021-00519-8","article-title":"Advancing therapy for osteosarcoma","volume":"18","author":"Gill","year":"2021","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.bone.2026.118070_bb0030","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.canlet.2013.11.017","article-title":"NVP-BEZ235, a dual PI3K\/mTOR inhibitor, inhibits osteosarcoma cell proliferation and tumor development in vivo with an improved survival rate","volume":"344","author":"Gobin","year":"2014","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bone.2026.118070_bb0035","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/2719172","article-title":"Construction and validation of a potent epigenetic modification-related prognostic signature for osteosarcoma patients","volume":"2021","author":"Liu","year":"2021","journal-title":"J. Oncol."},{"key":"10.1016\/j.bone.2026.118070_bb0040","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1186\/s13018-021-02422-5","article-title":"Potential role of m6A RNA methylation regulators in osteosarcoma and its clinical prognostic value","volume":"16","author":"Liu","year":"2021","journal-title":"J. Orthop. Surg. Res."},{"key":"10.1016\/j.bone.2026.118070_bb0045","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1186\/s12964-022-00939-8","article-title":"Impact of N6-methyladenosine (m(6)A) modification on immunity","volume":"20","author":"Elsabbagh","year":"2022","journal-title":"Cell Commun. Signal."},{"key":"10.1016\/j.bone.2026.118070_bb0050","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/s12943-020-01204-7","article-title":"The potential role of RNA N6-methyladenosine in cancer progression","volume":"19","author":"Wang","year":"2020","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.bone.2026.118070_bb0055","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1007\/s12035-022-02739-0","article-title":"N6-methyladenosine and neurological diseases","volume":"59","author":"Zhang","year":"2022","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.bone.2026.118070_bb0060","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s40246-022-00384-1","article-title":"The role of m6A methylation in osteosarcoma biological processes and its potential clinical value","volume":"16","author":"Wu","year":"2022","journal-title":"Hum. Genomics"},{"key":"10.1016\/j.bone.2026.118070_bb0065","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.pbiomolbio.2024.10.003","article-title":"m6A methylation regulators and ncRNAs in osteosarcoma: potential therapeutic strategies","volume":"194","author":"Shi","year":"2024","journal-title":"Prog. Biophys. Mol. Biol."},{"key":"10.1016\/j.bone.2026.118070_bb0070","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s13062-024-00486-x","article-title":"METTL3 promotes the progression of osteosarcoma through the N6-methyladenosine modification of MCAM via IGF2BP1","volume":"19","author":"Song","year":"2024","journal-title":"Biol. Direct"},{"key":"10.1016\/j.bone.2026.118070_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.104019","article-title":"ALKBH5 regulates STAT3 activity to affect the proliferation and tumorigenicity of osteosarcoma via an m6A-YTHDF2-dependent manner","volume":"80","author":"Yang","year":"2022","journal-title":"EBioMedicine"},{"key":"10.1016\/j.bone.2026.118070_bb0080","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1038\/s41422-022-00735-6","article-title":"Targeting UHRF1-SAP30-MXD4 axis for leukemia initiating cell eradication in myeloid leukemia","volume":"32","author":"Hu","year":"2022","journal-title":"Cell Res."},{"key":"10.1016\/j.bone.2026.118070_bb0085","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.162831","article-title":"Liposomal UHRF1 siRNA shows lung fibrosis treatment potential through regulation of fibroblast activation","volume":"7","author":"D Cheng","year":"2022","journal-title":"JCI Insight"},{"key":"10.1016\/j.bone.2026.118070_bb0090","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2024.2347757","article-title":"Prevotella copri exhausts intrinsic indole-3-pyruvic acid in the host to promote breast cancer progression: inactivation of AMPK via UHRF1-mediated negative regulation","volume":"16","author":"Su","year":"2024","journal-title":"Gut Microbes"},{"key":"10.1016\/j.bone.2026.118070_bb0095","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1186\/s13578-024-01333-2","article-title":"SIRT6 deficiency impairs the deacetylation and ubiquitination of UHRF1 to strengthen glycolysis and lactate secretion in bladder cancer","volume":"14","author":"Wang","year":"2024","journal-title":"Cell Biosci."},{"key":"10.1016\/j.bone.2026.118070_bb0100","doi-asserted-by":"crossref","first-page":"3776","DOI":"10.7150\/thno.69494","article-title":"Crosstalk between macrophage-derived PGE(2) and tumor UHRF1 drives hepatocellular carcinoma progression","volume":"12","author":"Zhang","year":"2022","journal-title":"Theranostics"},{"key":"10.1016\/j.bone.2026.118070_bb0105","first-page":"45","article-title":"CircFAT1 suppresses colorectal cancer development through regulating miR-520b\/UHRF1 axis or miR-302c-3p\/UHRF1 axis","volume":"36","author":"Hu","year":"2021","journal-title":"Cancer Biother. Radiopharm."},{"key":"10.1016\/j.bone.2026.118070_bb0110","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/s41419-023-05895-w","article-title":"UHRF1 inhibition epigenetically reprograms cancer stem cells to suppress the tumorigenic phenotype of hepatocellular carcinoma","volume":"14","author":"Wang","year":"2023","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bone.2026.118070_bb0115","doi-asserted-by":"crossref","first-page":"315","DOI":"10.3892\/mmr.2015.4515","article-title":"UHRF1 promotes human osteosarcoma cell invasion by downregulating the expression of E-cadherin in an Rb1-dependent manner","volume":"13","author":"Liu","year":"2016","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.bone.2026.118070_bb0120","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/s41389-022-00430-6","article-title":"UHRF1 overexpression promotes osteosarcoma metastasis through altered exosome production and AMPK\/SEMA3E suppression","volume":"11","author":"Wu","year":"2022","journal-title":"Oncogenesis"},{"key":"10.1016\/j.bone.2026.118070_bb0125","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.3001862","article-title":"The transcription factor HBP1 promotes ferroptosis in tumor cells by regulating the UHRF1-CDO1 axis","volume":"21","author":"Yang","year":"2023","journal-title":"PLoS Biol."},{"key":"10.1016\/j.bone.2026.118070_bb0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2021.121110","article-title":"Application of glutathione depletion in cancer therapy: Enhanced ROS-based therapy, ferroptosis, and chemotherapy","volume":"277","author":"Niu","year":"2021","journal-title":"Biomaterials"},{"key":"10.1016\/j.bone.2026.118070_bb0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbo.2021.100380","article-title":"Targeting ferroptosis in osteosarcoma","volume":"30","author":"Zhao","year":"2021","journal-title":"J. Bone Oncol."},{"key":"10.1016\/j.bone.2026.118070_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbo.2022.100412","article-title":"MiR-451a promotes cell growth, migration and EMT in osteosarcoma by regulating YTHDC1-mediated m6A methylation to activate the AKT\/mTOR signaling pathway","volume":"33","author":"Cao","year":"2022","journal-title":"J. Bone Oncol."},{"key":"10.1016\/j.bone.2026.118070_bb0145","doi-asserted-by":"crossref","first-page":"5236","DOI":"10.1080\/21655979.2022.2037381","article-title":"Methylation recognition protein YTH N6-methyladenosine RNA binding protein 1 (YTHDF1) regulates the proliferation, migration and invasion of osteosarcoma by regulating m6A level of CCR4-NOT transcription complex subunit 7 (CNOT7)","volume":"13","author":"Wei","year":"2022","journal-title":"Bioengineered"},{"key":"10.1016\/j.bone.2026.118070_bb0150","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s12964-023-01321-y","article-title":"NAT10 mediated ac4C acetylation driven m(6)A modification via involvement of YTHDC1-LDHA\/PFKM regulates glycolysis and promotes osteosarcoma","volume":"22","author":"Mei","year":"2024","journal-title":"Cell Commun. Signal."},{"key":"10.1016\/j.bone.2026.118070_bb0155","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1038\/s41419-023-06265-2","article-title":"The roles of m6A methylation in cervical cancer: functions, molecular mechanisms, and clinical applications","volume":"14","author":"Mao","year":"2023","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bone.2026.118070_bb0160","doi-asserted-by":"crossref","DOI":"10.1186\/s12943-023-01782-2","article-title":"The role of m6A methylation in therapy resistance in cancer","volume":"22","author":"H Zhuang","year":"2023","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.bone.2026.118070_bb0165","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s13046-024-02965-5","article-title":"The epigenetic downregulation of LncGHRLOS mediated by RNA m6A methylase ZCCHC4 promotes colorectal cancer tumorigenesis","volume":"43","author":"Chen","year":"2024","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.bone.2026.118070_bb0170","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1038\/s41467-021-21514-8","article-title":"RNA m6A methylation orchestrates cancer growth and metastasis via macrophage reprogramming","volume":"12","author":"Yin","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bone.2026.118070_bb0175","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s12943-022-01530-y","article-title":"Ferroptosis in cancer therapy: a novel approach to reversing drug resistance","volume":"21","author":"Zhang","year":"2022","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.bone.2026.118070_bb0180","article-title":"The N6-methyladenosine modification enhances ferroptosis resistance through inhibiting SLC7A11 mRNA deadenylation in hepatoblastoma","volume":"12","author":"Liu","year":"2022","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/j.bone.2026.118070_bb0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2025.144060","article-title":"Mechanism of UHRF1 protein macromolecule regulating ferroptosis in liver cancer: inhibition of GSTZ1 expression through DNA methylation","volume":"311","author":"Zhan","year":"2025","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.bone.2026.118070_bb0190","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1007\/s10753-023-01940-0","article-title":"Upregulation of UHRF1 promotes PINK1-mediated mitophagy to alleviates ferroptosis in diabetic nephropathy","volume":"47","author":"Ji","year":"2024","journal-title":"Inflammation"},{"key":"10.1016\/j.bone.2026.118070_bb0195","article-title":"Osteosarcoma cells and undifferentiated human mesenchymal stromal cells are more susceptible to ferroptosis than differentiated human mesenchymal stromal cells","volume":"14","author":"Smirnova","year":"2025","journal-title":"Antioxidants (Basel, Switzerland)"},{"key":"10.1016\/j.bone.2026.118070_bb0200","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.freeradbiomed.2024.12.040","article-title":"High-adhesion ovarian cancer cell resistance to ferroptosis: the activation of NRF2\/FSP1 pathway by junctional adhesion molecule JAM3","volume":"228","author":"Wang","year":"2025","journal-title":"Free Radic. Biol. Med."}],"container-title":["Bone"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328226002966?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328226002966?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T03:40:31Z","timestamp":1790739631000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S8756328226002966"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":40,"alternative-id":["S8756328226002966"],"URL":"https:\/\/doi.org\/10.1016\/j.bone.2026.118070","relation":{},"ISSN":["8756-3282"],"issn-type":[{"value":"8756-3282","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"ZCCHC4-mediated m6A methylation regulates the UHRF1\/CDO1 axis to inhibit ferroptosis and promote osteosarcoma malignant progression","name":"articletitle","label":"Article Title"},{"value":"Bone","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bone.2026.118070","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"118070"}}